Search
Close this search box.
Contact Us

Way Towards New Life

Immunosuppressant Drugs

Alleviare promptly facilitates Indian patients and physicians under Named Patient Programs (NPP) to access imported authorized medicines that are not locally available to them.
Facebook Twitter Youtube

Get access to an unapproved drug for personal use.

Here is a list of some of the Immunosuppressant Drugs for which we currently have a NPP in place. If you are a patient or  healthcare professional, please click below on each to access details and information.

BENLYSTA (belimumab) injection

BENLYSTA is a prescription medicine used for the treatment of a type of nephritis (kidney inflammation) that’s caused by lupus.
Click here

DUPIXENT (dupilumab) injection

DUPIXENT is a prescription medicine used for the treatment of Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyposis, Eosinophilic Esophagitis, Prurigo Nodularis.
Click here

Ilaris (canakinumab) for injection

Indicated for the treatment of adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) following
Click here

NPLATE (romiplostim) for injection

NPLATE is a brand-name prescription medication that’s used to treat thrombocytopenia.
Click here

NUCALA (mepolizumab) injection

Nucala is a brand-name prescription medication. It’s used to treat two conditions: severe eosinophilic asthma in adults and children ages 12 years and older.
Click here

SKYRIZI (risankizumab-rzaa) injection

SKYRIZI is a prescription medicine used for the treatment of plaque psoriasis, psoriatic arthritis and Crohn’s disease.
Click here

TALTZ (ixekizumab) injection

TALTZ is a prescription medicine used for the treatment of plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and active non-radiographic axial spondyloarthritis.
Click here

TREMFYA (guselkumab) injection

TREMFYA is a prescription medicine used for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Click here

RINVOQ (upadacitinib) Tablets

RINVOQ is a prescription medicine used to treat adults with moderate to severe ulcerative colitis when 1 or more medicines called tumor necrosis factor (TNF) blockers have been used,
Click here

For Indian Patient Enquiry under NPP.

Email At
kamal.kaushal@alleviareindia.com
laxmi.singh@alleviareindia.com
Call At
+91 98182 74099 ( Kamal Kaushal)
+91 9289711088 (Ms. Laxmi Singh)
WhatsApp At
+91 98182 74099 ( Kamal Kaushal)
+91 9289711088 (Ms. Laxmi Singh)

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Query Form

We would love to speak with you.
Feel free to reach out using the below details.

Get Access to an Unapproved Drug

Get access to an unapproved drug for personal use to following cities in India – Ahmedabad, Aizawal, Aurangabad, Barshi, Bengaluru, Bhopal, Cachar, Chennai, Dibrugarh, Hyderabad, Karungapally, Kohima, Kollam, Kolkata, Mumbai, Meghalaya, Mizoram, Sikkim, Nagpur, New Delhi, Pondichery, Pune, Punjab, Thirunananthapuram, Tripura, Wardha

Disclaimer

All Trademarks and Brands that appear on the website belong to their respective owners. Alleviare provides only information & in any way, does not lay any claim on these brand names &/or trademarks.

Opening Hours:
Monday – Saturday 10am – 6pm
Email – contact@alleviareindia.com

Contact Address:
P: 011: 35017784 / 35017785
M/W: +91 9289711087 / 9289711088

Address:
Mezzanine Floor, S-9, Green Park Extension, South Delhi, Delhi, 110016

Instagram Facebook-f Linkedin

DISCLAIMER: The services of Alleviare Life Sciences do not replace a physician-patient relationship and are not intended as medical advice. Alleviare Life Sciences provides patients and physicians with new medicine options by providing safe and secure access to approved medicines from other countries. We only provide this service after the patient and physician have made a professional decision on the treatment.

© 2023 Alleviare Life Sciences Pvt. Ltd.

Terms and Conditions | Privacy Policy | Legal Disclaimer